Showing 49–64 of 147 results
-
ISENTRESS (raltegravir) Film-Coated Tablets
Read more -
IXEMPRA Kit (ixabepilone) for Injection, for intravenous infusion only Initial U.S. Approval: 2007
Read more -
Jakavi (ruxolitinib) Tablets
Read more -
JEMPERLI (dostarlimab-gxly) injection
Read more -
KADCYLA (ado-trastuzumab emtansine) for injection, for intravenous use. Initial U.S. Approval: 2013
Read more -
KEYTRUDA (pembrolizumab) injection, for intravenous use Initial U.S. Approval: 2014
Read more -
KIMMTRAK (tebentafusp-tebn) injection
Read more -
KORLYM (mifepristone) 300 mg Tablets Initial U.S. Approval 2000
Read more -
LIBTAYO (cemiplimab-rwlc) injection, for intravenous use. Initial U.S. Approval: 09/2018
Read more -
LONSURF (trifluridine and tipiracil) tablets, for oral use. Initial U.S. Approval: 2015
Read more -
LUCENTIS (ranibizumab injection) Intravitreal Injection. Initial U.S. Approval: 2006
Read more -
LUMAKRAS (sotorasib) tablets. Get Access In India
Read more -
LYTGOBI (futibatinib) tablets
Read more -
MACRILEN (macimorelin) for oral solution. Initial U.S. Approval: 2017
Read more -
MEKINIST (trametinib) tablets, for oral use. Initial U.S. Approval: 2013
Read more -
MONJUVI (tafasitamab-cxix) for injection. FDA-Approved. To treat lymphoma
Read more